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a b s t r a c t
Emerging evidence indicates that mitochondrial cardiolipins (CL) are prone to free radical oxidation and
this process appears to be intimately associated with multiple biological functions of mitochondria. Our
previous work demonstrated that a signiﬁcant amount of potent lipid electrophiles including 4-hydroxy-
nonenal (4-HNE) was generated from CL oxidation through a novel chemical mechanism. Here we
provide further evidence that a characteristic class of CL oxidation products, epoxyalcohol-aldehyde-CL
(EAA-CL), is formed through this novel mechanism in isolated mice liver mitochondria when treated
with the pro-apoptotic protein t-Bid to induce cyt c release. Generation of these oxidation products are
dose-dependently attenuated by a peroxidase inhibitor acetaminophen (ApAP). Using a mouse model of
atherosclerosis, we detected signiﬁcant amount of these CL oxidation products in liver tissue of low
density lipoprotein receptor knockout (LDLR /) mice after Western diet feeding. Our studies
highlight the importance of lipid electrophiles formation from CL oxidation in the settings of apoptosis
and atherosclerosis as inhibition of CL oxidation and lipid electrophiles formation may have potential
therapeutic value in diseases linked to oxidant stress and mitochondrial dysfunctions.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
Cardiolipin (CL) is a class of phospholipids that contain four
fatty acid side chains and three glycerol backbones in the same
molecule. CLs are a structurally unique class of phospholipids as
phospholipids commonly have two fatty acids and one glycerol
unit. CLs primarily reside in the inner membrane of mitochondria
and are critical for maintaining the structural integrity of mito-
chondrial membranes and functions of multiple protein complexes
in the electron transport chain (ETC) [1]. In most mammalian
tissues, a majority of CLs contain four linoleic acid (LA, 18:2, ω-6)
chains (tetralinoleoyl CL, L4CL). The fatty acid composition of CL
appears to be an important factor for maintaining mitochondrial
function [2]. Furthermore, mitochondrion is the major cellular
source for reactive oxygen species (ROS) including superoxide and
hydrogen peroxide (H2O2). Incorporation of four LA side chains in
CLs and their association with mitochondria render CL to be
readily oxidized by ROS [3]. The mechanisms for this seemingly
paradoxical combination remain to be elucidated. Cardiolipin
oxidation has attracted increased research attention in recent
years and emerging evidence shows that it is critically involved
in regulation of apoptosis [4], mitochondrial dysfunction, mito-
phagy [5], and several human diseases [6]. Upon apoptotic
stimulation, CL interacts with cytochrome c (cyt c) to form a
peroxidase complex that catalyzes CL oxidation. Accumulating
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evidence indicates that these oxidation products of CL play an
important role in the mitochondrial stage of the cell death
program [1,7].
Oxidative stress-induced lipid peroxidation has been linked to
numerous human diseases including atherosclerosis [8,9]. Poly-
unsaturated fatty acids (PUFAs) such as LA in cell membranes are
the primary targets for free radicals attack [8]. Lipid peroxidation
generates an array of oxidation products and one class of these
products, reactive lipid electrophiles, is increasingly recognized as
an important lipid mediator due to its potential to alter protein
structure and functions by covalent modiﬁcation of certain critical
nucleophilic amino acid residues. 4-Hydroxy-2-nonenal (4-HNE) is
one of the most studied reactive lipid electrophiles and it can
trigger multiple signaling pathways in different biological pro-
cesses [10]. Elevated levels of 4-HNE were observed in athero-
sclerotic lesions and liver tissues and were positively correlated
with cell death in these tissues [11,12]. In contrast to the well-
studied pleiotropic biology of 4-HNE, mechanisms responsible for
4-HNE formation in vivo are much less understood [13,14]. Our
previous in vitrowork demonstrated that oxidation of L4CL by cyt c
and H2O2 led to the formation of 4-HNE and other oxidation
products via a novel chemical mechanism that involved cross-
chain peroxyl radical addition and decomposition [16]. As shown
in Fig. 1, oxidation of L4CL by the peroxidase activity of cyt c and CL
complex in the presence of H2O2 results in the formation of
hydroperoxyoctadecadienoic acid (HpODE). HpODE can be
reduced to form hydroxyoctadienoic acid (HODE) or dehydrated
to form keto-octadecadienoic acid (KODE). During this process,
through intra-molecular peroxyl radical addition and decomposi-
tion of an unstable intermediate, several reactive aldehydes are
produced including epoxyalcohol-aldehyde-CL (EAA-CL) (1 d), 4-
HNE (1e), and 4-oxo-2-nonenal (4-ONE) (1f). 4-HNE and 4-ONE
are diffusible electrophiles that can reach protein targets far away
from the generation sites but EAA-CL most likely targets only
closely associated proteins. Moreover, the formation of this unique
EAA-CL can serve as a footprint for this novel chemical mechanism
in vivo. However, the biological relevance of these lipid electro-
philes EAA-CL from CL oxidation remains to be deﬁned.
In this study, we provide mass spectrometry (MS) evidence for
this class of characteristic bioactive lipid electrophiles EAA-CL
from cardiolipin oxidation in the context of apoptosis using t-Bid
induced cyt c release in isolated mice liver mitochondria. Inter-
estingly, we observed dose-dependent inhibition of CL oxidation
and formation of EAA-CL by a widely used analgesic drug acet-
aminophen (ApAP) that also served as a peroxidase inhibitor [15].
Furthermore, the very mechanism appeared to operate in vivo in
the settings of atherosclerosis in a mice model of Western diet-
induced atherosclerosis using low density lipoprotein receptor
knockout (LDLR /) mice. We found signiﬁcant amounts of EAA-
CL present in the mice liver after Western diet feeding. Taking
these data together, our current study shed light on CL oxidation
and lipid electrophiles production relevant to apoptosis and
atherosclerosis, with inhibition of this process appearing to be a
viable strategy for preventing cyt c release and apoptosis.
Methods and materials
Materials
Phospholipids, tetralinoleoyl cardiolipin (L4CL) and tetramyris-
teoyl cardiolipin (M4CL) were purchased from Avanti Polar Lipids
(Alabaster, AL, USA) and used without further puriﬁcation. All
other chemicals were purchased from Sigma Aldrich Chemical
Company (Milwaukee, WI). HPLC quality solvents, such as metha-
nol, water, 2-propanol, and acetonitrile were purchased from
either Fisher Chemical (Phillipsburg, NJ) or EM Science
(Gibbstown, NJ).
Animals and diets
LDLR / mice were originally purchased from Jackson
Laboratory. At 2–3 month of age, these mice were fed a Western
diet (TD 88,137, Harlan Teklad, Madison, WI) containing 0.2%
cholesterol and 21.2% fat or normal chow diet for 16 weeks. At
the end of 16 weeks, the mice were food-deprived for 5 h and
sacriﬁced by an overdose of isoﬂurane followed by cervical
dislocation. All animal experiments were performed according to
protocols approved by the Institutional Animal Care and Use
Committee of Shanghai Institutes for Biological Sciences.
Oil Red O staining of liver sections
Oil red O staining of liver section was performed according to a
literature procedure [16]. Brieﬂy, liver samples were embedded in
an optimal cutting temperature compound (Tissue-Tek), and were
frozen at 20 1C. Liver sections were cut and stained with Oil Red
O for 4 h. Sections were then counterstained with hematoxylin for
3 min. Images were captured using a Q-Imaging Micropublisher
camera mounted on an Olympus upright microscope.
Quantiﬁcation of oxidation products of CL by liquid chromatography–
mass spectrometry (LC–MS)
The MS analysis of oxidized CL was performed according to our
previously published methods [15,17]. After addition of 0.75% NaCl
to the liver mitochondria pellet or homogenized liver tissue, the
total lipids were extracted with chloroform and methanol (2:1, v:
v) containing 0.1mM butylated hydroxytoluene (BHT) and 0.1mM
triphenylphosphine. The separated organic phase was evaporated,
re-suspended in methanol:acetonitrile:H2O (60/20/20, v/v/v) and
stored at 80 1C until analysis by LC–MS. The extracted lipid
fraction was separated online by UPLC using a Waters Acquity
UPLC system (Waters Corp., Milford, MA). Mass spectrometry
analysis was performed on a Thermo Quantum Ultra or Vantage
triple quadrupole mass spectrometer (Thermo Scientiﬁc Inc., San
Jose, CA, USA). The mass spectrometer was operated in the
negative ion mode using selective reaction monitoring (SRM).
Nitrogen was used as the sheath gas and auxiliary gas. The
capillary temperature was set at 350 1C. The spray voltage was
4.5 kV, and the tube lens voltage was 100 V. The following
Fig. 1. Proposed chemical mechanism for lipid electrophiles formation from L4CL
oxidation.Only one regioisomer at carbon 13 (C13) is shown in the ﬁgure for
simplicity.
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transitions were monitored in SRM mode: M4CL, m/z 619.6–227.2;
L4CL, m/z 723.6–279.2; L3OCL, m/z 724.6–279.2; HODE-L4CL, m/z
731.6–279.2, 295.2; HODE-L3OCL, m/z 732.6–279.2, 295.2; KODE-
L4CL, m/z 730.6–279.2, 293.2; KODE-L3OCL, m/z 731.6–279.2,
293.2; EAA-L4CL, m/z 685.6–279.2; EAA-L3OCL, m/z 686.6–279.2.
Data acquisition and analysis were performed using X’calibur
software, version 2.0.
The area under the curve (AUC) for M4CL, CL, KODE-CL, HODE-
CL, EAA-CL and MLCL was determined and the AUC of each CL in
each sample was normalized to M4CL AUC. The corrected values
were used to calculate the ratio of corresponding CL over the total
CL and was expressed as percent of total CL. Data are presented as
the mean 7 SEM.
t-Bid induces CL oxidation in isolated mitochondria
Mouse liver mitochondria were isolated as previously
described [15,18]. Fifteen microgram of mitochondria were incu-
bated in 100 μl experimental buffer (250 mM sucrose, 10 mM
Hepes, pH 7.4, 1 mM ATP, 5 mM succinate, 0.08 mM ADP, 1 mM
dithiothreitol, and 2 mM K2HPO4, pH 7.4). After addition of 10 ng
t-Bid, the samples were incubated for 30 min at room tempera-
ture. Mitochondria were pelleted by centrifugation at 8000 rpm
for 10 min at 4 1C. The oxidation products of CL in the pellets were
extracted as described above.
ApAP inhibits CL oxidation and in isolated mitochondria
Fifteen microgram of energized mitochondria were pre-
incubated with 0–400 μM ApAP for 10 min. CL oxidation induced
by t-Bid was processed as described above.
2.7. Statistical analysis
Results are expressed as means 7 SD. Statistical analysis was
performed using t tests. A probability value of p o 0.05 was
considered statistically signiﬁcant.
Results
Formation of Lipid electrophile EAA-CL from cardiolipin oxidation
in vitro during t-Bid Induced cyt c release from mitochondria
Mitochondria play a central role in cell survival and apoptosis.
The apoptotic pathways are highly orchestrated by pro- and anti-
apoptotic Bcl-2 superfamily protein members. Bid is an abundant
pro-apoptotic protein of the Bcl-2 family that is crucial for death
receptor-mediated apoptosis in many cell types. It has been well
established that t-Bid, a truncated form of Bid, facilitates the
disruption of the mitochondrial trans-membrane potential and
the release of apoptogenic proteins including cyt c. During this
process, t-Bid also causes the remodeling of mitochondrial cristae
and CL oxidation [19]. To test the biological relevance of lipid
electrophile generation from CL oxidation during apoptosis, we
treated mice liver mitochondria with t-Bid to induce cyt c release
and identiﬁed the production of EAA-CL using mass spectrometry
(shown in Fig. 2). We performed LC–MS analysis using the
collision-induced dissociation (CID) of m/z 685 (doubly charged,
Fig. 2A), the putative structure of EAA-CL, in the negative ion
mode. A fragment with m/z 279 in the CID spectrum (Fig. 2B) was
consistent with the presence of linoleate side chains while m/z 171
and 311 represented the presence of side chains of truncated
aldehyde at C9 and epoxyalcohol-aldehyde LA moiety respectively.
Other fragments such as m/z 1091.5 and 307 were consistent with
the proposed structure. Thus our MS data provided unambiguous
evidence for the formation of this novel lipid electrophile from CL
oxidation. In addition, other oxidation products such as HODE-CL
were also identiﬁed by CID experiment (data not shown). We
further performed quantitative analysis of the major oxidation
products using multiple reaction monitoring (MRM) by monitor-
ing the transition of each parent ion to their respective character-
istic fragmentation (Fig. 2C). The MRM results clearly
demonstrated the formation of multiple oxidation products
including EAA-CL and HODE-CL. Their elution order on a reverse
phase LC column was consistent with the polarity of each
compound. Furthermore, our previous work demonstrated that
ApAP served as an inhibitor of the peroxidase activity of cyt c/CL
complex. We then tested the ability of ApAP to inhibit the
Fig. 2. t-Bid induces EAA-L4CL formation in isolated mitochondria and ApAP dose-
dependently inhibits L4CL oxidation and epoxyalcohol-aldehyde-CL formation.
(A) Total ion chromatogram (TIC) of m/z 685.5 (doubly charged) in isolated
mitochondria when treated with t-Bid. Arrow shows the putative EAA-CL peak.
(B) MS spectrum of CID of m/z 685.5 at 6.33 min, EAA-CL. (C) MRM analysis of L4CL
oxidation products in isolated mitochondria after t-Bid treatment. SRM transitions
are shown in Methods. (D) ApAP inhibits L4CL oxidation and EAA-CL formation.
L4CL oxidation products are expressed as % of relative inhibition.
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formation these reactive lipid electrophiles and our data clearly
showed that ApAP dose-dependently attenuated the formation of
EAA-CL and HODE-CL (Fig. 2D).
Formation of lipid electrophiles from CL oxidation in liver tissue of
LDLR KO mice
Oxidative stress is a hallmark of atherogenesis and free radical
lipid peroxidation has been associated with every stage of this
disease [20]. LDLR / is a well-established mouse model used to
study atherosclerosis. 4-HNE was identiﬁed in mouse athero-
sclerotic lesions and liver, and levels of 4-HNE were associated
with cell death in these tissues [21]. We employed this mouse
model to test if EAA-CL and other cardiolipin oxidation products
were formed in the liver during the formation of atherosclerotic
plaques in the aorta. Western diet feeding for 16 weeks resulted in
signiﬁcant atherosclerotic lesion formation in the aortas as
revealed by Red Oil O staining (Fig. 3A). We analyzed the liver
tissues in these animals and identiﬁed multiple oxidation products
from CL oxidation including 4-HNE, EAA-CL, KODE-CL, and HODE-
CL (Fig. 3B). Furthermore, levels of EAA-CL from liver tissue of
Western diet group were signiﬁcantly elevated compared to that
from the control group. These data represent the ﬁrst in vivo
evidence for the formation of these novel lipid electrophiles, EAA-
CL, from mitochondrial cardiolipin during atherosclerosis.
Besides the major cardiolipin species L4CL, mouse liver tissue
contains other minor cardiolipins such as L3OCL. The structure of
L3OCL has one of the LA side chains replaced by an oleic acid.
According to our chemical mechanism of 4-HNE formation from
CL, cross-chain peroxyl radical reaction occurs between two
adjacent side chains; thus the presence of an unreactive oleic acid
side chain in L3OCL may disrupt this reaction and lead to less lipid
electrophile production through this mechanism. As shown in
Fig. 4, our data showed that the formation of similar electrophiles
EAA-CL from L3OCL was indeed signiﬁcantly suppressed compared
to those from L4CL, highlighting the importance of this cross-chain
reaction during the formation of reactive electrophiles. Interest-
ingly, formation of other major oxidation products, such as HODE-
CL, from L3OCL was decreased compared to L4CL but did not reach
statistical signiﬁcance.
Discussion
Free radical-induced lipid peroxidation has been linked to
multiple human diseases including atherosclerosis [8]. Among
the complicated oxidation products, lipid electrophiles, including
4-HNE, generated from lipid oxidation have attracted increased
attention due to their potential roles in altering protein structures
and functions through covalent modiﬁcation of critical nucleophi-
lic amino acid residues [10,21,22]. Overwhelming evidence indi-
cates that mitochondria play an essential role in ROS generation,
lipid peroxidation, and the pleiotropic effects of 4-HNE in various
biological processes. In contrast to the well-studied biology of
4-HNE, the chemical mechanisms for 4-HNE formation and cel-
lular locations remain poorly deﬁned [23,24]. In a previous report
we proposed a novel chemical mechanism for the formation of 4-
HNE and other reactive lipid aldehydes from mitochondrial
cardiolipin oxidation [17]. In our current study, we provide
evidence that this mechanism operates both in vitro in t-Bid
induced cyt c release and in vivo in mice liver of atherosclerosis
after Western diet feeding. Furthermore, formation of these
bioactive lipid mediators can be dose-dependently inhibited by a
widely used clinical reagent ApAP acting as a peroxidase inhibitor,
corroborating with previous studies where ApAP was a potent
inhibitor for peroxidase activity of cylooxygense (COX)[25], hemo-
proteins including hemoglobin and myoglobin [26], and perox-
idase of cyt c/CL complex [15]. Our ﬁndings have signiﬁcant
implications in linking mitochondrial lipid peroxidation and lipid
electrophile production to important biological processes, such as
Fig. 3. EAA-L4CL and L4CL oxidation present in LDLR KO mice liver after high fat
feeding.(A) Oil red O staining of atherosclerotic lesions at the aortic root after
Western diet feeding. Images are shown at 10 magniﬁcation. (B) Quantiﬁcation
of L4CL oxidation products in LDLR KO mice liver using MRM. MRM transitions:
(a) EAA-L4CL, m/z 685.6 to 279.2; (b) L4CL, m/z 723.6 to 279.2; (c and d) KODE-
L4CL, m/z 730.6 to 293.2 and 279.2; (e and f) HODE- L4CL, m/z 731.6 to 279.2 and
295.2. (C) Levels of EAA-CL in LDLR KO mice liver fed control diet and western diet.
EAA-CL is expressed as % of total CL (means 7 SD, n ¼ 4 chow diet vs n ¼ 6
western diet).
Fig. 4. Level of EAA-CL from L3OCL is decreased than that from L4CL in LDLR KO
mice liver due to the presence of one un-reactive fatty acid. (A) Chemical structure
of L3OCL. (B) Levels of oxidation products of L3OCL and L4CL from LDLR KO mice
liver after feeding Western diet. CL oxidation products are expressed as % of total CL
(means 7 SD, n ¼ 6).
H. Zhong et al. / Redox Biology 2 (2014) 878–883 881
apoptosis, and human diseases that are associated with oxidative
stress.
The novel chemical mechanisms for the formation of 4-HNE
from CL oxidation are based on the fact that the extent of oxidation
for L4CL is far greater than other phospholipids. The susceptibility
of L4CL to free radical oxidation has been attributed to the
presence of four LA side chains in the same molecules and the
rate-limiting step reaction of hydrogen atom abstraction by a
peroxyl radical may occur through intra-molecular reactions.
Furthermore, subsequent peroxyl radical addition reactions that
form cross-chain products may be responsible for the formation of
4-HNE. A seminal work reported by Kagan et al. demonstrated that
oxidation of CL by the peroxidase function of cyt c/CL complex was
required to trigger intrinsic apoptotic pathways [27]. Recent stu-
dies from the same group also reported that CL oxidation was
linked to traumatic brain injury [28] and mitophagy [5]. However,
the role of bioactive lipid electrophiles from CL oxidation remains
to be studied. Our studies suggest that 4-HNE formation from this
process may also play a signiﬁcant role in these events because 4-
HNE has been shown to induce apoptosis and autophage
[10,29,30]. Moreover, it is well established that 4-HNE plays an
important role in cardiovascular diseases. On one hand, 4-HNE
directly suppresses contractile function, enhances ROS generation,
and modulates multiple signal transduction pathways that are
known to contribute to atherosclerosis, myocardial ischemia-
reperfusion injury, heart failure, and cardiomyopathy [21]. On
the other hand, levels of circulating anti-cardiolipin antibody are
positively correlated with endothelial dysfunction and athero-
sclerosis. It is interesting to note that the anti-cardiolipin antibody
actually recognized oxidized CL [31]. Formation of these epitopes
is most likely through covalent modiﬁcations of immune respon-
sive proteins by lipid electrophiles generated from CL oxidation
[32]. Moreover, L4CL is the major CL species in the mitochondria of
most mammalian tissues and it constitutes more than 70% of
mitochondrial CLs in the heart [33]. Thus formation of 4-HNE via
this novel mechanism is likely important in the context of
cardiovascular diseases. Our current study clearly demonstrates
that formation of 4-HNE from CL operates in vivo and has
signiﬁcant pathophysiological relevance with the detection of the
characteristic product EAA-CL and other CL oxidation products
(Fig. 3). This mechanism is further substantiated by the observa-
tion that the presence of only one un-oxidized fatty acid (such as
oleic acid) in some minor cardiolipin species signiﬁcantly
decreases the formation of this characteristic bioactive lipid and
other oxidation products such as HODE-CL (Fig. 4).
Modulating the formation of 4-HNE and other lipid electro-
philes from CL oxidation in mitochondria may represent a viable
approach to attenuate the cytotoxicity of these bioactive lipid
electrophiles. Several strategies have been explored to inhibit the
oxidation of CL in mitochondria [34]. The peroxidase activity of cyt
c/CL complex is activated by hydrogen peroxide or lipid hydroper-
oxides; thus scavenging H2O2 or reducing lipid hydroperoxides
may lead to the inhibition of apoptosis [35]. In fact, liver apoptosis
and cyt c release were suppressed in transgenic mice over-
expression of phospholipid hydroperoxide glutathione peroxidase
(PHGPX), the enzyme that reduces lipid hydroperoxides. Levels of
cardiolipin oxidation products in these transgenic animals were
also suppressed compared to the wild type animals [36]. Further-
more, reduction of mitochondrial hydrogen peroxide by over-
expressing mitochondria-speciﬁc peroxiredoxin 3 (Prdx3/Prx3)
led to reduced levels of F2-IsoPs, a widely accepted standard for
oxidative stress in vivo [37,38], and 4-HNE [39]. Inhibition of the
peroxidase activity of cyt c/CL complex represents a novel
approach for controlling CL oxidation and its related conse-
quences. ApAP is one of the most widely used analgesics. Previous
studies show that it inhibited peroxidase activity of COX by
reducing the protoporphyrin radical cation in the peroxidase
active site of the enzyme, thereby blocking formation of the
catalytic tyrosyl radical in the cyclooxygenase site [25,40]. Later
studies demonstrated that ApAP could protect the kidney from
oxidative damage following rhabdomyolysis by inhibiting the
peroxide-driven lipid peroxidation catalyzed by myoglobin and
hemoglobin [41]. We reported recently that ApAP inhibited cyt c
redox cycling-induced lipid peroxidation [15]. In current studies,
in addition to suppression of the CL oxidation products such as
HODE-CL, lipid electrophiles including EAA-CL are also signiﬁ-
cantly inhibited during t-Bid induced cyt c release (Fig. 2). It is still
unclear, however, how the phospholipid containing lipid electro-
philes, such as EAA-CL, are metabolized or repaired. The metabolic
pathways for these novel phospholipid electrophiles and their
biological activities are currently under investigation.
In summary, we provide evidence that, in addition to 4-HNE, a
novel class of CL containing lipid electrophiles, EAA-CL, are
generated from mitochondrial CL oxidation in vitro and in vivo in
the context of apoptosis and atherosclerosis. The widely used
clinical reagent ApAP can inhibit CL oxidation and generation of
those lipid electrophiles. This study suggests a potential link
between mitochondrial CL oxidation, lipid electrophile generation,
mitochondrial dysfunction, and apoptosis during the progression
of atherosclerosis.
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